Patent ID: 11958899
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 19:
20. An isolated nucleic acid molecule that encodes at least a portion of the anti-C1s antibody of claim 1, wherein the nucleic acid comprises at least one nucleotide sequence selected from
a. a heavy-chain (HC) nucleotide sequence selected from: a nucleotide sequence comprising the sequence of SEQ ID NO: 5, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 5, a nucleotide sequence comprising the sequence of SEQ ID NO: 15, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 15, a nucleotide sequence comprising the sequence of SEQ ID NO. 25, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 25, a nucleotide sequence comprising the sequence of SEQ ID NO: 35, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 35, a nucleotide sequence comprising the sequence of SEQ ID NO: 45, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 45, a nucleotide sequence comprising the sequence of SEQ ID NO: 55, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 55, a nucleotide sequence comprising the sequence of SEQ ID NO: 65, and a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 65, and
b. a light chain (LC) nucleotide sequence selected from: a nucleotide sequence comprising the sequence of SEQ ID NO: 10, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 10, a nucleotide sequence comprising the sequence of SEQ ID NO: 20, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 20, a nucleotide sequence comprising the sequence of SEQ ID NO. 30, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 30, a nucleotide sequence comprising the sequence of SEQ ID NO: 40, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 40, a nucleotide sequence comprising the sequence of SEQ ID NO: 50, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 50, a nucleotide sequence comprising the sequence of SEQ ID NO: 60, a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 60, a nucleotide sequence comprising the sequence of SEQ ID NO: 70, and a nucleotide sequence comprising a sequence at least about 85% identical to SEQ ID NO: 70.